BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 14566096)

  • 21. Maximum-likelihood estimation of haplotype frequencies in nuclear families.
    Becker T; Knapp M
    Genet Epidemiol; 2004 Jul; 27(1):21-32. PubMed ID: 15185400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
    Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA
    Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient semiparametric estimation of haplotype-disease associations in case-cohort and nested case-control studies.
    Zeng D; Lin DY; Avery CL; North KE; Bray MS
    Biostatistics; 2006 Jul; 7(3):486-502. PubMed ID: 16500923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HAPLOFREQ--estimating haplotype frequencies efficiently.
    Halperin E; Hazan E
    J Comput Biol; 2006 Mar; 13(2):481-500. PubMed ID: 16597253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical performance of cladistic strategies for haplotype grouping in pharmacogenetics.
    Lunceford JK; Liu N
    Stat Med; 2008 Dec; 27(28):5816-33. PubMed ID: 18696749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haplotype-based association analysis in cohort and nested case-control studies.
    Chen J; Chatterjee N
    Biometrics; 2006 Mar; 62(1):28-35. PubMed ID: 16542226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying bias due to allele misclassification in case-control studies of haplotypes.
    Govindarajulu US; Spiegelman D; Miller KL; Kraft P
    Genet Epidemiol; 2006 Nov; 30(7):590-601. PubMed ID: 16830341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variation in CYP17 and endometrial cancer risk.
    Gaudet MM; Lacey JV; Lissowska J; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
    Hum Genet; 2008 Mar; 123(2):155-62. PubMed ID: 18172694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating haplotype-disease associations with pooled genotype data.
    Zeng D; Lin DY
    Genet Epidemiol; 2005 Jan; 28(1):70-82. PubMed ID: 15558554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-Stage sampling designs for gene association studies.
    Thomas D; Xie R; Gebregziabher M
    Genet Epidemiol; 2004 Dec; 27(4):401-14. PubMed ID: 15543639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Logistic regression model for analyzing extended haplotype data.
    Wallenstein S; Hodge SE; Weston A
    Genet Epidemiol; 1998; 15(2):173-81. PubMed ID: 9554554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of untyped SNPs: maximum likelihood and imputation methods.
    Hu YJ; Lin DY
    Genet Epidemiol; 2010 Dec; 34(8):803-15. PubMed ID: 21104886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.
    Cui JS; Spurdle AB; Southey MC; Dite GS; Venter DJ; McCredie MR; Giles GG; Chenevix-Trench G; Hopper JL
    Genet Epidemiol; 2003 Apr; 24(3):161-72. PubMed ID: 12652520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical methods for haplotype-based matched case-control association studies.
    Zhang H; Zhang H; Li Z; Zheng G
    Genet Epidemiol; 2007 May; 31(4):316-26. PubMed ID: 17285622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating genotyping uncertainty in haplotype frequency estimation in pedigree studies.
    Zhu WS; Fung WK; Guo J
    Hum Hered; 2007; 64(3):172-81. PubMed ID: 17536211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data.
    Fallin D; Schork NJ
    Am J Hum Genet; 2000 Oct; 67(4):947-59. PubMed ID: 10954684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
    Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
    In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How about the uncertainty in the haplotypes in the population-based KORA studies?].
    Heid IM; Lamina C; Bongardt F; Fischer G; Klopp N; Huth C; Küchenhoff H; Kronenberg F; Wichmann HE; Illig T
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S132-6. PubMed ID: 16032531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous estimation of haplotype frequencies and quantitative trait parameters: applications to the test of association between phenotype and diplotype configuration.
    Shibata K; Ito T; Kitamura Y; Iwasaki N; Tanaka H; Kamatani N
    Genetics; 2004 Sep; 168(1):525-39. PubMed ID: 15454562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined haplotype relative risk (CHRR): a general and simple genetic association test that combines trios and unrelated case-controls.
    Guo CY; Lunetta KL; DeStefano AL; Cupples LA
    Genet Epidemiol; 2009 Jan; 33(1):54-62. PubMed ID: 18636528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.